{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:40:46Z","timestamp":1740156046982,"version":"3.37.3"},"reference-count":6,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.eprac.2024.07.005","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T23:17:48Z","timestamp":1720567068000},"page":"893-894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Parenteral Estradiol for Transgender Women: Time to Adjust the Dose"],"prefix":"10.1016","volume":"30","author":[{"given":"Kayla T.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-5853","authenticated-orcid":false,"given":"Vin","family":"Tangpricha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.eprac.2024.07.005_bib1","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.eprac.2024.05.008","article-title":"The use of injectable estradiol in transgender and gender diverse adults: a scoping review of dose and serum estradiol levels","volume":"30","author":"Rothman","year":"2024","journal-title":"Endocr Pract"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2024.07.005_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"3","key":"10.1016\/j.eprac.2024.07.005_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.eprac.2024.07.005_bib4","first-page":"272","article-title":"Assessing and addressing the risk\u00a0of venous thromboembolism across the spectrum of gender affirming care: a review","volume":"29","author":"Arrington-Sanders","year":"2023","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2024.07.005_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4158\/EP-2020-0414","article-title":"Serum hormone concentrations in transgender individuals receiving gender-affirming hormone therapy: a longitudinal retrospective cohort study","volume":"27","author":"Chantrapanichkul","year":"2021","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.eprac.2024.07.005_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.eprac.2023.02.006","article-title":"Comparison of the subcutaneous and intramuscular estradiol regimens as part of\u00a0gender-affirming hormone therapy","volume":"29","author":"Herndon","year":"2023","journal-title":"Endocr Pract"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T17:16:18Z","timestamp":1725297378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24006037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1530891X24006037"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.07.005","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parenteral Estradiol for Transgender Women: Time to Adjust the Dose","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.05.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}